Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients (2007)
- Authors:
- USP affiliated authors: PASINI, FÁTIMA SOLANGE - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM
- Unidade: FM
- Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO; CARCINOMA DE CÉLULAS ESCAMOSAS; BIOMARCADORES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Abstracts
- Volume/Número/Paginação/Ano: p. 190, res. P197, 2007
- Conference titles: Oral Oncology Head and Neck Oncology & Pathology
-
ABNT
SNITCOVSKY, I. et al. Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. 2007, Anais.. Amsterdam: Faculdade de Medicina, Universidade de São Paulo, 2007. p. 190. . Acesso em: 20 maio 2024. -
APA
Snitcovsky, I., Bruniati, K., Leitão, G., Pasini, F., Federico, M., Castro, G., et al. (2007). Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. In Abstracts (p. 190). Amsterdam: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Snitcovsky I, Bruniati K, Leitão G, Pasini F, Federico M, Castro G, Carreiro K, Campoflorito C, Villar R, Mangone F, Maistro S. Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. Abstracts. 2007 ; 190.[citado 2024 maio 20 ] -
Vancouver
Snitcovsky I, Bruniati K, Leitão G, Pasini F, Federico M, Castro G, Carreiro K, Campoflorito C, Villar R, Mangone F, Maistro S. Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. Abstracts. 2007 ; 190.[citado 2024 maio 20 ] - Determination of plasma osteopontin levels in patients with head and neck squamous cell carcinoma
- HMGCR MRNA expression in tongue squamous cell carcinoma
- Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT)
- New possible predictive marker of survival in oral squamous cell carcinoma
- Gene expression pattern of primary oral cancer is predictive of cervical lymph node metastases
- Expression of CXCR1 and 'CX IND. 3'CR1 mRNA seems to outocome of the larynx squamous cell carcinoma
- Avaliação prospectiva de polimorfismo genéticos da glutationa-s-transferase P1 como fator prognóstico e preditivo de resposta em pacientes portadores de carcinoma epidermóide de cabeça e pescoço tratados com quimiorradioterapia
- Identification of polymorphisms and germline mutations in BRCA1 genes in breast cancer patients indicated for genetic test
- ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
- Expressão de G3BP2 como fator prognóstico de sobrevida em pacientes com carcinoma epidermóide de cavidade oral
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
